InnoGene Co (344860.KQ) Stock Price

InnoGene Co Price

CLOSED
1,389.00
-1.00 (-0.07 %)
Market closed

Over the last 6 years InnoGene Co grew revenue by 2.3% annually, reaching 8.94 B KRW. Earnings per share have grown at 2.3% per year over the last 6 years. For InnoGene Co, the net margin of 10.6% is broadly stable versus 11.0% a few years ago. At today's price the dividend yield works out to roughly 5.76%. The payout ratio is around 101% of earnings. The stock trades about 15% above its 52-week low.

InnoGene Co stock price

Access this data via the Eulerpool API

InnoGene Co business model & stock analysis

Frequently asked questions about InnoGene Co

Converted at the current exchange rate, the InnoGene Co share trades at 0.90 EUR (1,389.00 KRW).

No history available for InnoGene Co.

The revenue cannot currently be calculated for InnoGene Co.

The profit cannot currently be calculated for InnoGene Co.

The P/E ratio cannot be calculated for InnoGene Co at the moment.

The P/S cannot be calculated for InnoGene Co currently.

The Eulerpool Quality Score for InnoGene Co is 1/10.

The ISIN of InnoGene Co is KR7344860002. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of InnoGene Co is 344860.KQ. The ticker symbol is used to trade InnoGene Co shares on the stock exchange.

Over the past 12 months, InnoGene Co paid a dividend of 80.00 KRW . This corresponds to a dividend yield of about 5.76 %. For the coming 12 months, InnoGene Co is expected to pay a dividend of 110.00 KRW.

The current dividend yield of InnoGene Co is 5.76 %.

InnoGene Co paid dividends every year for the past 0 years.

For the upcoming 12 months, dividends amounting to 110.00 KRW are expected. This corresponds to a dividend yield of 7.92 %.

InnoGene Co is assigned to the 'Non-cyclical consumption' sector.

To receive the latest dividend of InnoGene Co from 4/11/2025 amounting to 80 KRW, you needed to have the stock in your portfolio before the ex-date on 12/27/2024.

The last dividend was paid out on 4/11/2025.

In the year 2024, InnoGene Co distributed 80 KRW as dividends.

The dividends of InnoGene Co are distributed in KRW.

Fair ValueTerminal
1,333.44 KRW
Over-/UndervaluationTerminal
Fairly valued
Industry
Personal Care Products
Number of shares
Employees
Revenue per Employee
116.16 M KRW
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website innogene.com
Country
South Korea
Currency
KRW
Initial public offering
Apr 27, 2020
ISIN
KR7344860002
Cusip
Y4R87G106
Market capitalization
16.61 B KRWLarge Cap
52-Week Range
1,205.00–2,255.00KRW
Revenue growth (10Y) > 5%
Revenue growth (3Y) > 5 %
EBIT growth (10Y) > 5%
EBIT growth (3Y) > 5 %
Net debt < 4x EBIT
Profitable since 10Y+
EBIT Drawdown (10Y) < 50%
Return on Equity (ROE) > 15%
ROCE > 15%
Return Expectation > 10%
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
24.46
P/B Ratio
1.00
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
5.66 %
Gross Margin
74.18 %
EBIT Margin
7.05 %
Net Margin
10.57 %
EPS (Earnings Per Share)
79.04 KRW
Net Debt / EBIT
-1.88
Debt/Equity
0.00
Dividend
Dividend yield
5.76 %
Payout Ratio
101.22 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
0 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
22.00 %
Last updated Sep 27, 2026, 4:55 PM

InnoGene Co Peer Group

InnoGene Co FIGI

344860:KS · BBG00TCNH4X9344860:KQ · BBG00TCNH4Z7